Clinical trial
Phase 2a, Multicenter, Randomized, Patient and Evaluator Blinded, Controlled Study Evaluating the Safety and Efficacy of NTX-001 Compared to SOC in the Treatment of Acute Single Transected Peripheral Nerve Injury Occurring Below the Distal Border of the Brachial Plexus Requiring Surgical Repair.
NCT04572906 is registered in ClinicalTrials.gov with Neuraptive Therapeutics Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Phase 2a, Multicenter, Randomized, Patient and Evaluator Blinded, Controlled Study Evaluating the Safety and Efficacy of NTX-001 Compared to SOC in the Treatment of Acute Single Transected Peripheral Nerve Injury Occurring Below the Distal Border of the Brachial Plexus Requiring Surgical Repair.
- Lead sponsor
- Neuraptive Therapeutics Inc.
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 25, 2020
- Completion date
- June 27, 2024
- Enrollment
- 51 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.